CC · Categories · Downgrades
CC - Analyst downgrades
Chemours Company (CC) analyst downgrades - real-time wire coverage filtered to Downgrades only.
Recent Downgrades for CC
- Chemours downgraded by Mizuho with a new price targetMizuho downgraded Chemours from Outperform to Neutral and set a new price target of $15.00
- Chemours downgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts downgraded Chemours from Outperform to Sector Perform and set a new price target of $14.00
- Chemours downgraded by UBS with a new price targetUBS downgraded Chemours from Buy to Neutral and set a new price target of $18.00
- Chemours downgraded by UBS with a new price targetUBS downgraded Chemours from Buy to Neutral and set a new price target of $21.00 from $37.00 previously
- Chemours downgraded by BMO Capital Markets with a new price targetBMO Capital Markets downgraded Chemours from Outperform to Underperform and set a new price target of $19.00 from $45.00 previously
- Chemours downgraded by BofA Securities with a new price targetBofA Securities downgraded Chemours from Buy to Neutral and set a new price target of $37.00 from $41.00 previously
- Chemours downgraded by RBC Capital Mkts with a new price targetRBC Capital Mkts downgraded Chemours from Outperform to Sector Perform and set a new price target of $33.00 from $35.00 previously
- Chemours downgraded by ArgusArgus downgraded Chemours from Buy to Hold
- Chemours downgraded by BofA Securities with a new price targetBofA Securities downgraded Chemours from Buy to Neutral and set a new price target of $44.00 from $48.00 previously